Speakers

Lowbury Lecture

Prof Brett Mitchell

Professor Mitchell AM is an internationally renowned clinician researcher in the field of infection prevention and control. He is Editor-in-Chief of Infection, Disease and Health, with appointments at Avondale University (Professor of Nursing and Health Services Research), the Central Coast Local Health District and Monash University. Brett’s research provides high quality evidence to inform infection control practice.  He has over 150 peer reviewed publications and has received several prestigious national awards for his contributions, including an Order of Australia and Commonwealth Health Ministers award for excellence in health and medical research. Prof Mitchell has served on several national committees in Australia and abroad, and is a Fellow of the Australasian College for Infection Prevention and Control. Brett has led infection control teams and programs at the hospital and State level. His interests include environmental cleaning, catheter-associated urinary tract infections, non-ventilator associated pneumonia and the infection control workforce

JD Williams Lecture 

Prof Shiranee Sriskandan 

Shiranee Sriskandan is a Clinical Professor of Infectious Diseases at Imperial College and Head of the Section of Adult Infectious Diseases, based at Hammersmith Hospital. She is also co-Director of Imperial's Centre for Bacterial Resistance Biology (CBRB) and a theme lead for the NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infection and Antimicrobial Resistance.She leads research on Streptococcus pyogenes, the bacterium that causes tonsillitis and scarlet fever, but also invasive infections such as necrotising fasciitis, maternal sepsis, and toxic shock. In the developing world, S. pyogenes is also associated with rheumatic fever, a major cause of valvular heart disease. Despite the burden of illness, there is no vaccine, and this is an active area of research at present.Research in the Gram Positive Pathogenesis group is also driven by unexpected changes in either the bacteria causing disease, or the disease itself, in particular patient disease severity or epidemiology. This has led to work on novel streptococcal proteases that cleave chemokines, that might function as vaccine targets, as well as unexpected routes of bacterial dissemination in the lymphatic system. It has also led to identification of new sublineages of serotypes M89 and M1 S. pyogenes (M1UK); expansion of these lineages has accounted for increasing proportions of invasive infections worldwide.

Alan Winston
Imperial College Healthcare NHS Trust

Amy Belfield
Newcastle Hospitals, UK

Andrew Seaton
NHS Greater Glasgow and Clyde UK

Aneeka Chavda
Imperial College Healthcare NHS Trust, UK

Angela Huttner
Geneva University Hospitals, Switzerland

Anna Goodman
Guy's and St Thomas' NHS Foundation, UK

Anne Neary
Liverpool NHS Foundation Trust, UK

April Baller
WHO Health Emergencies Programme, Switzerland

Beatriz Larru Martinez
Alder Hey Children's NHS Foundation Trust, Liverpool, UK

Bernadette Young
Oxford University Hospitals NHS Foundation Trust, UK

Catrin Thomas
Public Health Wales, UK

Chris Kosmidis
Manchester University NHS Foundation Trust, UK

Christian Giske
OHD, Sweden

Christine Peters
Queen Elizabeth University Hospital, UK

Darlington Akogo
CEO, MinoHealth AI Labs, Ghana

Bibi Slingerland
Erasmus University Medical Centre, Netherlands

Eleanor Morgan
London School of Tropical Medicine, UK

Emma Hooker
ARHAI Scotland, UK

Enrique Castro-Sanchez
UKHSA, UK

Faye Greenwood
Liverpool University Hospitals NHS Trust, UK

Francesco Cogliati
Virgen Macarena University Hospital, Seville

Gehan Fahmy
Ain Shams University, Egypt

Gordon Mackay
NHS Lanarkshire, UK

Graham Pike
Oxford University Hospitals NHS Foundation Trust, UK

Helen Brotherton
University of St Andrews School of Medicine, UK

James Price
Brighton and Sussex Medical School, UK

Jean-Paul Pirnay
Queen Astrid Military Hospital, Belgium

Jessica Blackaby
Public Health Wales, UK

Jessica Martin
Frimley Health NHS Foundation Trust, UK

Jincy Jerry
NHS Ayrshire and Arran, UK

Joanna Harris
UKHSA, UK

John Cuddihy
TRAMSSMART Limited, UK

Joseph Meletiadis
University of Athens, Greece

Kathleen O'Reilly
London School of Hygiene and Tropical Medicine, UK

Katie Hopkins
UK Health Security Agency, UK

Kavita Sethi
Leeds Teaching Hospitals NHS Trust, UK

Killian Quinn
King's College Hospital, UK

Laura Maynard-Smith
University College London Hospitals NHS Foundation Trust, UK

Laura Shallcross
UCL Institute of Health Informatics, UK

Louisa Pollock
NHS Greater Glasgow and Clyde, UK

Luke Moore
Chelsea and Westminster Hospital NHS Foundation Trust, UK

Mario Ramirez
University of Lisbon, Portugal

Mariyam Mirfenderesky
Royal Free London NHS Foundation Trust, UK

Mark Gilchrist
Imperial College Healthcare, NHS Trust, UK

Martyn Wilkinson
University Hospitals Birmingham NHS Foundation Trust, UK

Michael Blank
Imperial College, London, UK 

Natasha Ratnaraja
University Hospitals Coventry and Warwickshire, UK

Neil Stone
University College London Hospitals, UK

Nicholas Wong
Liverpool University Hospitals NHS Foundation Trust, UK

Nigel Simpson
Leeds Teaching Hospitals NHS Trust, UK

Novella Cesta
University Hospital Company, Italy 

Rachelle McDade
Currie & Brown, UK

Ran Nir-Paz Hadassah
Hebrew University Medical Center, Israel

Rob Shorten
Lancashire Teaching Hospital, UK

Ruth Payne
Sheffield Teaching Hospitals NHS Foundation Trust, UK

Stacy Todd
University Hospitals of Liverpool Group, UK

Susan Hopkins
UKHSA, UK

Susie Dodd
 ARHAI Scotland, UK

Tom Parks
Imperial College London, UK

Vicky Tittle
Chelsea and Westminster NHS Trust, UK

Victoria Hall
UKHSA, UK

Walter Zingg
University Hospital Zurich